FDA.reportPublic FDA data

obinutuzumab 1000 MG in 40 ML Injection

RxCUI
1442693
RxNorm name
obinutuzumab 1000 MG in 40 ML Injection
Display name
obinutuzumab 1000 MG in 40 ML Injection
Full name
obinutuzumab 1000 MG in 40 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125486Gazyvaobinutuzumab351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
df12ceb2-5b4b-4ab5-a317-2a36bf2a3cdaobinutuzumab 1000 MG in 40 ML Injection [PSN] · 40 ML obinutuzumab 25 MG/ML Injection [SCD] · obinutuzumab 1000 MG per 40 ML Injection [SY]322These highlights do not include all the information needed to use GAZYVA safely and effectively. See full prescribing information for GAZYVA. GAZYVA ® (obinutuzumab) injection, for intravenous use Initial U.S. Approval: 201320251219